Citation:Bhat S, Coleman HG, Yousef F, Johnston BT, McManus DT, Gavin AT, et al 2011

From Cancer Guidelines Wiki

Citation


Bhat S, Coleman HG, Yousef F, Johnston BT, McManus DT, Gavin AT, et al. Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study. J Natl Cancer Inst 2011 Jul 6;103(13):1049-57 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/21680910.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
What is the incidence of neoplasia in patients with BO?Associate Professor Freddy Sitascompleted
What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?Professor David Whiteman B Med Sci, MBBS (Hons) PhD FAFPHMcompleted
Are there groups of patients with non-dysplastic BO that require more frequent surveillance?Dr Henry Tocompleted
Are there groups of patients with BO that can be discharged from surveillance?Conjoint Associate Professor Philip Craigcompleted
How frequently should patients with BO undergo endoscopy?Dr Bradley Kendall MBBS, FRACPcompleted

Compare quality appraisals for each clinical question

Cited by

  1. Are there groups of patients with BO that can be discharged from surveillance?
  2. Are there groups of patients with non-dysplastic BO that require more frequent surveillance?
  3. How frequently should patients with BO undergo endoscopy?
  4. Is surveillance cost-effective for follow-up of patients with BO?
  5. What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?
  6. What is the endoscopic definition of BO and how is it described?
  7. What is the histological definition of BO?
  8. What is the incidence of neoplasia in patients with BO?